PsoraxPlan | A feasibility study on the development of Psorax35 as the first and only oral treatment for mild-to-moderate psoriasis with positive effects on co-morbidities.
01-08-2019
-31-01-2020
Show more information
Organisation
ARCTIC NUTRITION AS